Q2 results and raised 2026 guidance

Vertex posts a strong Q2 and raises the 2026 revenue bar

The quarter landed well enough that she moved the full-year number up rather than sitting on the beat.

raising guidance in august is a confidence signal you can't walk back quietly. she'd rather set a higher bar in public than let anyone price vertex as a one-drug company coasting on trikafta.

Q2 print carried by multiple outlets